Short Interest in NKGen Biotech, Inc. (NASDAQ:NKGNW) Rises By 1,193.3%

NKGen Biotech, Inc. (NASDAQ:NKGNW) saw a large growth in short interest in October. As of October 31st, there was short interest totalling 19,400 shares, a growth of 1,193.3% from the October 15th total of 1,500 shares. Based on an average daily volume of 8,000 shares, the days-to-cover ratio is presently 2.4 days.

NKGen Biotech Stock Performance

Shares of NASDAQ NKGNW traded up $0.06 during trading hours on Wednesday, reaching $0.09. The stock had a trading volume of 5,402 shares, compared to its average volume of 16,826. NKGen Biotech has a twelve month low of $0.02 and a twelve month high of $0.29. The business’s fifty day moving average is $0.05 and its two-hundred day moving average is $0.08.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.